How It Works
- Unmasks Cancer Cells: Makes cancer cells visible to immune defenses.
- Activates Immune Cells: Stimulates T-cells and NK cells to attack and destroy cancer cells.
Cancer care has entered a new era where treatments do more than just attack tumorsâthey empower the patientâs immune system. Targeted immunotherapy is a precision approach that identifies specific markers on cancer cells, allowing doctors to direct the immune system to fight cancer more effectively while minimizing damage to healthy tissue. Patients in Kanpur now have access to world-class targeted immunotherapy, bringing advanced, research-driven oncology care closer to home.
Contact UsTargeted immunotherapy is a revolutionary cancer treatment that uses biologics or drugs to stimulate the immune system against cancer cells. Unlike chemotherapy, which attacks all rapidly dividing cells, immunotherapy is highly selective, focusing only on cancer cells with specific molecular markers.
Targeted immunotherapy works differently from chemotherapy or conventional therapy, offering greater precision and fewer side effects:
Targeted immunotherapy is highly effective for specific cancers, especially where conventional therapy has limited success:
Targeted immunotherapy provides precision treatment that enhances the immune system, leading to improved outcomes and quality of life:
Immunotherapy treatment is carefully planned and monitored to maximize effectiveness:
Kanpur now offers access to advanced immunotherapy with experienced specialists and modern facilities:
Dr. Yuvraj Singh, a leading Radiation Oncologist in Kanpur, provides advanced Targeted Immunotherapy treatment with a patient-first approach.
Understanding the treatment process can ease concerns.
Schedule your appointment today with Dr. Yuvraj Singh, leading Immunotherapy Specialist in Kanpur, for precise, safe, and world-class cancer care.
It strengthens the immune system to fight cancer cells, unlike chemotherapy which attacks both healthy and cancer cells.
Yes, leading oncology centers now offer advanced immunotherapy treatments.
Eligibility depends on molecular profiling and tumor markers.
Usually mild (fatigue, skin rash, flu-like symptoms), though rare immune-related reactions can occur.
Varies by cancer type; some continue for months, others stop once remission is achieved.